• Agenda

• Brochure

•  CE Credit

• Course Director & Faculty

•  Registration

Target Audience
Physicians, hematologist-oncologists, nurses and all others interested in hematologic malignancy and hematopoietic stem cell transplantation.

Agenda
7:30-09:00 am
Registration

9:00-9:15 am
Welcome Remarks

9:15-9:45 am
Optimization of Bone Marrow Transplant and Cellular Therapy Inpatient Care
Corinne Shamehdi, MPAS, PA-C

9:50-10:20 am
Advancements in AML
Amir Fathi, MD

10:25-10:40 am
Break

10:40-11:10 am
Advancements in Relapsed Refractory Multiple Myeloma
Saad Usmani, MD

11:15-11:30 am
Q&A

11:30-12:45 pm
Lunch

12:45-1:15 am
Herzig Memorial Lecture: Updates on Management of Aggressive Lymphoma
John Leonard, MD

1:20-1:50 pm
Frontline Therapies in Multiple Myeloma
Nina Shah, MD

1:55-2:05 pm
Break

2:05-2:35 pm
Chronic Lymphocytic Leukemia in 2023: Continued Changing Paradigms
Catherine Coombs, MD

2:40-3:10 pm
Advances in the Management of MDS
Rami Komrokji, MD

3:15-3:45 pm
Q&A

3:50-4:20 pm
Frontline Treatment of Adult ALL in 2023
Nicholas Short, MD

4:25 pm
Conclusive Remarks
            
6:00 pm
Dinner

Course Director
Mohamed Hegazi, MD
Assistant Professor of Medicine
Section Chief, Blood Cancers, Cellular Therapeutics and Transplantation
Associate Director, Hematology/Oncology Fellowship Program
UofL Health - Brown Cancer Center
Louisville, KY


Course Faculty
Catherine Coombs, MD
Associate Clinical Professor
University of California
Irvine, CA

Amir Fathi, MD
Associate Professor of Medicine
Director Leukemia Program Massachusetts General Hospital
Boston, MA

Rami Komrokji, MD
Professor of Oncologic Sciences
Moffitt Cancer Center
Tampa, FL

John Leonard, MD
Senior Associate Dean for Innovation and Initiatives
Weill Cornell Medicine/New York Presbyterian
New York, NY

Nina Shah, MD
Professor of Medicine, Myeloma Specialist
UCSF Health-UCSF Medical Center
San Francisco, CA

Corinne Shamehdi, MPAS, PA-C
Inpatient Lead APP
Tampa General Hospital Cancer Institute
Tampa, FL

Nicholas Short, MD
Associate Professor
The University of Texas
MD Anderson Cancer Center
Houston, TX

Saad Usmani, MD    
Myeloma Specialist & Cellular Therapist
Memorial Sloan Kettering Cancer Center
New York, NY

Continuing Education Credit
Physician Credit - The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation
The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Nurses - This program has been approved by the Kentucky Board of Nursing for 5.4 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-24-1391. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation,

Special Services
To request disability arrangements, please contact  Rebecca Thurman at (502) 718-6511 at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Brochure
CLICK HERE for a copy of the course brochure (Available Soon)

Registration
Registration for this event is free but you must register in advance to allow for program planning.

CLICK HERE to Register for the Conference

Acknowledgments
We thank our participating companies for their support of the Louisville Hematology Highlights 2024 conference,  a final listing of supporters and exhibitors will be available at the meeting.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.